Eichenfield Lawrence 4
4 · Verrica Pharmaceuticals Inc. · Filed Jun 9, 2025
Insider Transaction Report
Form 4
Eichenfield Lawrence
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-05+20,000→ 20,000 totalExercise: $0.58Exp: 2035-06-04→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2025 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date.